PoliticalRepoPoliticalRepo

United Kingdom · Question · Written question

UIN 62774

Alzheimer's Disease: Drugs

Original

answeredUnited Kingdom· UK Parliament· EN

Introduced

25 June 2025

Last action

3 July 2025 · Answer

Status

Answered

Sponsors

Subjects

Discovery layer

Source updated

3 July 2025

Summary

To ask the Secretary of State for Health and Social Care, pursuant to the Answer of 25 June to Question 61301 on Alzheimer's Disease: Drugs, whether NICE has made an assessment of the potential impact of not publishing the economic models for (a) lecanema

This text is taken from the official record. PoliticalRepo does not editorialize.

Timeline

  1. 25 June 2025

    Written question

    To ask the Secretary of State for Health and Social Care, pursuant to the Answer of 25 June to Question 61301 on Alzheimer's Disease: Drugs, whether NICE has made an assessment of the potential impact of not publishing the economic models for (a) lecanema

    Source: Commons

  2. 3 July 2025

    Answer

    The National Institute for Health and Care Excellence’s (NICE) single technology appraisal process relies on information provided by companies to evaluate the clinical and cost-effectiveness of new treatments. Some of this information, including the econo...

    Source: Written answer

Votes

No vote records are attached yet.

Versions

No version snapshots stored. Document URLs remain at the source.

Documents

No documents linked.

Sponsors

Related records

No cross-record relationships stored yet.

Sources

PoliticalRepo is an index and interpretation layer, not the authoritative legal source.